Skip to main content
Clinical Trials/NCT04735770
NCT04735770CompletedNot Applicable

Laparoscopically Inserted Transversus Abdominis Plane Block Versus Wound Local Anesthesia in Laparoscopic Endometriosis Surgery: a Prospective Randomized Controlled Double-blinded LTAP-trial

Oulu University Hospital1 site in 1 country46 target enrollmentStarted: May 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
46
Locations
1
Primary Endpoint
Postoperative opioid consumption

Study Overview

Brief Summary

The purpose of this study is to compare the efficacy and safety of laparoscopically inserted transversus abdominis plane block (LTAP) in comparison to local wound analgesia in laparoscopic surgery due to suspected or diagnosed peritoneal endometriosis.

Detailed Description

The LTAP-trial is a prospective randomized controlled double-blinded study comparing the efficacy and safety of LTAP with local wound analgesia in laparoscopic endometriosis surgery. Patients are randomized to receive LTAP with levobupivacain and wound infiltration with placebo or wound infiltration with levobupivacain and LTAP with placebo. The primary outcome is postoperative opioid consumption measured by Patient Controlled Analgesia -pump (PCA). Secondly, subjective postoperative pain up to 24 h postoperatively will be measured by Numeric Rating Scale (NRS). Additional outcome measures are factors related to recovery and length of stay in the hospital as well as a 6 month follow-up survey regarding pain and general wellbeing after surgery. A total of 46 patients will be randomized in a proportion of 1:1.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Surgery indicated because of pain caused by diagnosed or suspected peritoneal endometriosis
  • •ASA class 1-3
  • •Patient is capable of giving informed consent

Exclusion Criteria

  • •Obstructive sleep apnea
  • •ASA class >4
  • •Other significant risks associated with opioid use
  • •Contraindications for local anesthetics or NSAIDs
  • •Regular opioid consumption before operation

Arms & Interventions

LTAP

Experimental

Patients receive laparoscopically inserted TAP block with levobupivacain and local wound anesthesia injections with saline.

Intervention: Postoperative pain management: LTAP block or local wound anesthesia with levobupivacaine (Procedure)

Local wound analgesia

Active Comparator

Patients receive laparoscopically inserted TAP block with saline and local wound anesthesia injections with levobupivacaine.

Intervention: Postoperative pain management: LTAP block or local wound anesthesia with levobupivacaine (Procedure)

Outcomes

Primary Outcomes

Postoperative opioid consumption

Time Frame: 24 hours

Oxicodone consumption measured via PCA-pump in Morphine equivalents

Secondary Outcomes

  • Pain at six months postoperatively; assessed by NRS (numeric rating scale), (questionnaires sent to the patients)(6 months postop)
  • Postoperative pain assessed by NRS (numeric rating scale)(Recovery room immediately postoperatively; on ward 6, 12 and 24 hours postoperatively)
  • Quality of life at six months postoperatively; assessed by EHP-30 (endometriosis-related health profile) (questionnaires sent to the patients)(6 months postop)
  • Intra- or postoperative complications(Up to 6 months postop)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Anna Terho

Principal Investigator

Oulu University Hospital

Study Sites (1)

Loading locations...

Similar Trials